Common bleeding drug put to test in High-Stakes brain surgeries
NCT ID NCT06229483
Summary
This study is testing if a drug called tranexamic acid (TXA) can safely reduce dangerous bleeding during surgery to remove brain tumors. Researchers will compare TXA against a placebo in 102 adults undergoing this operation to see if it lowers blood loss and prevents serious complications like re-operation or death. The goal is to provide clear evidence on whether this widely used medication should become a standard part of brain surgery care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nova Scotia Health Authority- Queen Elizabeth II Health Sciences Center
RECRUITINGHalifax, Nova Scotia, B3H3A7, Canada
Contact
Contact
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.